Dow Up 0.11% Nasdaq Up 0.50%

Kythera Biopharmaceuticals, Inc. (KYTH)

-NasdaqGS
37.61 Up 0.76(2.06%) Aug 29, 4:00PM EDT
Prev Close:36.85
Open:36.98
Bid:34.85 x 500
Ask:99.99 x 100
1y Target Est:53.60
Beta:-0.589
Earnings Date:Nov 12 - Nov 17 (Est.)
Day's Range:36.85 - 37.74
52wk Range:25.69 - 56.36
Volume:76,237
Avg Vol (3m):178,223
Market Cap:852.69M
P/E (ttm):N/A
EPS (ttm):-5.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KYTH

Comparison

Symbol% ChgMkt Cap
KYTHUp 2.06%852.69M
ZLTQUp 0.19%788.40M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.34
Quarterly EPS Est (Sep-14) :-0.88
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KYTHERA Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback